+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Global Cell Therapy Market Size was valued at USD 13.7 Billion in 2022. The Cell Therapy market industry is projected to grow from USD 14.6 Billion in 2023 to USD 30.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.80% during the forecast period (2023 - 2032). The increase in funding for cell therapy clinical research, the use of efficient manufacturing techniques, and the commercial success of novel products, are the key market drivers enhancing the market growth.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
The market for cell treatment is constantly seeing the introduction of new cell types, creating enormous opportunity for companies to strengthen their market positions. As a result, during the past several years, there has been a sharp rise in the number of companies developing cell therapies. The increase in funding for cell therapy clinical research, the adoption of useful standards for cell therapy production, and the success of novel products are some of the major factors influencing the growth in the number of businesses in the market. The cost of stem cell therapies has decreased, which has also raised consumer interest. The ability of the market to handle sizable volumes on a global scale has improved as a result of the establishment of cell banking facilities and the ensuing development of cell manufacturing, storage, and characterization. This is what has been directly responsible for the market's increased income generating during the previous few years.
A surge in the number of clinical studies can be attributed to the existence of both governmental and commercial financing organizations, which consistently approve projects to aid across all stages of clinical trials. In Europe, grants from the EU are the primary source of funding for late-stage projects. For instance, in July 2022, Achilles Therapeutics declared that company had been awarded a USD 4.2 million grant dubbed "Horizon Europe." It serves as the EU's primary funding initiative for research and innovation. Thanks to this assistance, the development of personalized medicines will advance. Stem cell therapy is also gaining prominence as a result of its applications in the treatment of autoimmune and metabolic disorders. Building one's immunity is essential if they are to be able to combat various metabolic issues. For instance, Sernova and Evotec decided to collaborate in May 2022 in order to create cell treatments based on induced pluripotent stem cells (iPSCs) for the treatment of insulin-dependent diabetes.
Automation in adult stem cell processing and storage as well as cord blood storage are the primary technologies projected to have a favorable impact on the market growth for adult and cord blood cells. Major market competitors are also collaborating to create induced pluripotent stem cells (iPSCs) from newborn stem cells derived from tissue and umbilical cord blood. These developments are likely to fuel market expansion over the course of the forecast timeframe.
An increase in the usage of human cells for research in cell therapies, technological advancements in the field of cell therapy, and an increase in the frequency of diseases like cancer and cardiac abnormalities are the main factors propelling the growth of the cell therapy market. Additionally, market expansion is anticipated to be constrained by the implementation of strict government regulations governing the use of cell therapy. However, it is projected that the market for cell therapy would benefit from an increase in the number of laws supporting stem cell therapy and an increase in research funding in developing countries. Thus, driving the Cell Therapy market revenue.
The global Cell Therapy market segmentation, based on Cell Type, includes stem cell and non-stem cell. Stem cell segment dominated the global market in 2022. This is a result of the growing demand for better, more effective drugs to address disorders of the cardiovascular, nervous, and immune systems. Stem cell therapy also goes by the term of cell regeneration treatment. Non-stem cells, on the other hand, will have the fastest rate of growth over the predicted time. The growth of new, healthy skin tissue and the generation of collagen can both be accelerated by non-stem cell therapy.
The global Cell Therapy market segmentation, based on Therapy Type, includes autologous and allogeneic. The autologous segment dominated the global market in 2022. In addition, it is predicted that this segment will grow more swiftly during the forecast period. The market is anticipated to grow as a result of the widespread use of CAR-T therapies and their positive effects in the treatment of numerous cancers and genetic disorders.
The global Cell Therapy market segmentation, based on Therapeutic Area, includes malignancies, musculoskeletal disorders, autoimmune disorders, dermatology, and others. The malignancies segment dominated the global Cell Therapy market in 2022. Due to CAR T-cells that target CD19, patients with acute lymphocytic leukemia (ALL) have reportedly seen high rates of complete and long-lasting remissions. Additionally, as the FDA continues to approve more novel treatments, it is projected that the market for cell therapies will grow.
The global Cell Therapy market segmentation, based on End User, includes hospitals & clinics and academic & research institutes. The hospital & clinics segment dominated the global Cell Therapy market in 2022. This is due to the expected increase in demand for gene and cell therapies. However, academic and research institutions are the category with the quickest development. The primary use of stem cells is research, which has generated a sizable income share for the research sector.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study. The North America Cell Therapy Market dominated this market in 2022 (45.80%). This is the outcome of research collaborations between leading academic institutions and the local pharmaceutical business. New improvements in the region have been made possible through numerous partnerships. Further, In the North American area, the U.S. Cell Therapy market had the biggest market share, while the Canada Cell Therapy market had the quickest rate of expansion.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Europe Cell Therapy market accounted for the healthy market share in 2022. Due to increased market participants' investments in the creation and application of cell-based therapies in the United States, it is projected that the market in Europe would expand. Further, In the European region, the German Cell Therapy market had the biggest market share, and the U.K. Cell Therapy market had the quickest rate of growth.
The Asia Pacific Cell Therapy market is expected to register significant growth from 2023 to 2032. This is due to the region's expanding demand for cell therapy. Several factors, including increased investments, rising investments in innovative medications, and anticipated favorable government regulations, are predicted to support market expansion during the forecast period. Moreover, In the Asia-Pacific region, the Indian Cell Therapy market had the quickest rate of growth while China's Cell Therapy market had the greatest market share.
Leading industry companies are making significant R&D investments in order to diversify their product offerings, which will drive the Cell Therapy market's expansion. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants are also engaging in a number of strategic actions to increase their global footprint. The Cell Therapy sector needs to provide affordable products if it wants to grow and thrive in a more competitive and challenging market environment.
One of the primary business strategies employed by manufacturers in the worldwide Cell Therapy industry to assist customers and expand the market sector is local manufacturing to reduce operational costs. Some of the biggest benefits to medicine have recently come from the Cell Therapy sector. Major players in the Cell Therapy market, including Kolon TissueGene Inc., AlloSource, Holostem Terapie Avanzate S.R.L., AlloSource, Holostem Terapie Avanzate S.R.L., Castle Creek Biosciences Inc., Anterogen Co. Ltd, Celgene Corporation, and Tameika Cell Technologies Inc., are attempting to increase market demand by investing in research and development Products.
Immunocore Holdings Plc (Immunocore) is a biotechnology company. It focuses on developing immunotherapeutic drugs to treat autoimmune, infectious, and malignant diseases. The company develops its medicines using its unique T cell receptor (TCR) technology. The IMC-C103C, IMC-F106C, IMC-I109V, IMC-M113V, and IMCgp100 products are currently under development. The company works with a number of pharmaceutical companies to develop its therapeutic candidates for the treatment of metastatic cutaneous melanoma, cancer, and other indications. In addition to the UK, it is found in the US, Australia, New Zealand, Asia, and Europe. Immunocore is based in Oxfordshire, a county in the United Kingdom. In January 2022, the Food and Drug Administration approved Immunocore's KIMMTRAK (tebentafusp-tebn) for the management of metastatic or incurable uveal melanoma.
Through the creation of cell-based regeneration medications, Novadip Biosciences seeks to increase patient access to tissue regeneration therapies. Clinicians and patients can improve clinical outcomes and long-term quality of life with the use of the company's therapies. These treatments use autologous adipose stem cells to treat bone diseases and deformities and aid in the repair of hard and soft tissues. The regenerative bone medication NVD-003 from Novadip Biosciences received FDA approval as an investigational new drug (IND) in March 2021 for the treatment of a rare paediatric bone disease.
· Kolon TissueGene Inc.
· AlloSource
· Holostem Terapie Avanzate S.R.L.
· AlloSource
· Holostem Terapie Avanzate S.R.L.
· Castle Creek Biosciences Inc.
· Anterogen Co. Ltd
· Celgene Corporation
· Tameika Cell Technologies Inc.
January 2022: Cellino Biotech, a manufacturer of cell treatments, raised USD 80 million in a Series A financing round. By developing the first autonomous human cell foundry by 2025, Cellino hopes to make stem cell-based treatments more widely available.
· Stem Cell
· Non-Stem Cell
· Autologous
· Allogeneic
· Malignancies
· Musculoskeletal Disorders
· Autoimmune Disorders
· Dermatology
· Others
· Hospitals & Clinics
· Academic & Research Institutes
· North America
- U.S.
- Canada
· Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
· Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
· Rest of the World
- Middle East
- Africa
- Latin America
|
Report Attribute/Metric |
Details |
|
Market Size 2022 |
USD 13.7 Billion |
|
Market Size 2023 |
USD 14.6 Billion |
|
Market Size 2032 |
USD 30.2 Billion |
|
Compound Annual Growth Rate (CAGR) |
7.80% (2023-2032) |
|
Base Year |
2022 |
|
Market Forecast Period |
2023-2032 |
|
Historical Data |
2018- 2022 |
|
Market Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Cell Type, Therapy Type, Therapeutic Area, End User, and Region |
|
Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
|
Countries Covered |
The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
|
Key Companies Profiled |
Kolon TissueGene Inc., AlloSource, Holostem Terapie Avanzate S.R.L., AlloSource, Holostem Terapie Avanzate S.R.L., Castle Creek Biosciences Inc., Anterogen Co. Ltd, Celgene Corporation, and Tameika Cell Technologies Inc. |
|
Key Market Opportunities |
Entering developing economies |
|
Key Market Dynamics |
The rise in funding for cell therapy clinical studies, the adoption of useful guidelines for cell therapy manufacturing, and the success of novel products |
The global Cell Therapy market size was valued at USD 13.7 Billion in 2022.
The global market is projected to grow at a CAGR of 7.80% during the forecast period, 2023-2032.
North America had the largest share in the global market
The key players in the market are Kolon TissueGene Inc., AlloSource, Holostem Terapie Avanzate S.R.L., AlloSource, Holostem Terapie Avanzate S.R.L., Castle Creek Biosciences Inc., Anterogen Co. Ltd, Celgene Corporation, and Tameika Cell Technologies Inc.
The Stem Cell Type dominated the market in 2022.
The Autologous Therapy Type had the largest share in the global market.
Research on the market is done by industry professionals who provide personalized insights on the industry structure, market segmentation, Type assessment, competitive landscape (CL), along with penetration, and emerging trends. In addition to years of professional experience in their various fields and sectors, their analysis is largely based on primary interview (60%) and secondary research (40%) as well as years of professional experience. In addition, our researchers forecast the market's direction over the following seven years by examining past trends and the market's current position. Additionally, various trends of segments and categories that are geographically portrayed are studied and estimated using primary and secondary research.
The key level executives (VP, CEO, Marketing Directors, and Business Development Managers) of the major industry participants who are active and prominent as well as mid-scale businesses operating in this market were interviewed in-depth for this supply-side report by overall Global Market Research.
Extensive primary research was conducted to gain a deeper grasp of the market and industry. Both primary and secondary research, as well as years of pertinent professional experience, are used to support the analysis. By analyzing past and present market patterns, our experts were able to forecast the market's course over the following seven years. For the geographically offered categories in the list of market tables, it differs per category. In connection with the Global Market research report, we also conducted a number of primary interviews with senior level executives (VP, CEO's, Directors, Marketing Directors, Business Development Managers, CFOs, Technical Consultants, Key Opinion Leaders, Industry Experts, Decision Matrix Authorities, and other crucial individuals) of the key industry players who dominated the Global market.
The primary purpose of secondary research was to gather, identify, and validate the information necessary for the thorough, technical, market-focused, and commercial analysis of the global market. With the use of this study, it was also possible to classify and segment the market in accordance with market trends, geographic markets, and regional considerations linked to market type. Analysts have gathered data in the Distribution Channel for the study of the market from reliable sources including annual reports, journals, white papers, corporate presentations, company websites, international organizations of Energy and Power manufacturers, credible paid databases, and many others to gather reliable intel.
Both top-down and bottom-up methodologies were employed to assess the accuracy of the global market size. The market for as a whole was estimated using these methods for a number of different dependent submarkets. Secondary research was used to address the major industry players, and primary and secondary research was used to calculate their market shares in the various regions. This complete intellectual process includes reading the annual and financial reports of the top market participants and conducting in-depth interviews with top industry executives (VP, CEO, Marketing Directors, and Business Development Managers) to gain important industry insights.
Through reliable secondary sources and validated primary sources, the classification of the global markets and their geographic percentage splits were established. To obtain the final qualitative and quantitative data, all relevant variables that might have an impact on the market under investigation have been taken into consideration, inspected in great depth, verified through primary research, and assessed. This information was collected, added to, and thoroughly examined by professional analysts before being provided in this report. The process used to estimate the overall market size for this study is depicted in the following image as an example.
Report Code :
RL65284
Published on :
Sep 2023
Request a Free Sample Report
Speak to Analyst